Sun Pharma tanks in trade for the second session, today down over 10 percent. This after Moneylife opens the whistle-blower complaint document to some institutional investors. The whistleblower alleges that Aditya Medisales was not declared as a related party till FY18 despite huge transactions between the two companies. Debashis Basu, founder of Moneylife shared his views and outlook.
